6DECEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comOver the years, the compliance landscape has changed drastically from self-regulatory to statutory enforcement, with the list of regulations continuously varying on the tides of global change. And in 2020, with every industry facing technological and fiscal disruptions, the pharma compliance industry is arguably experiencing the most significant upheaval in recent history. The luxury of having a little time at the beginning of each year to come up to speed on all the new trends influencing and reshaping industries has become a thing of the past. As the situation continues to evolve, businesses must assess how they can use their limited resources efficiently. Striking the right balance between a competent in-house team and strategically outsourcing relationships could present invaluable solutions and golden opportunities. With the growing number of compliance standards such as PCI, HIPAA, and more, organisations seek integrated solutions to track regulatory changes, tie them to business processes, conduct impact assessments, and finally, streamline policies and procedures. There is also a surge in the need for analytical solutions that can remotely monitor compliance risks in real-time and proactively fix inconsistencies. While meeting these requirements, new-age solutions need to be flexible enough to mitigate compliance risks and improve the client's productivity.Our editorial board at Pharma Tech Outlook has analysed the most popular trends of the year to assist industry leaders in manoeuvring in the right direction when adopting compliance consulting. We have filtered out the solutions that genuinely set themselves a league apart, and are crafted to not only outperform the rest of the pack but also solve pressing challenges prevailing in the industry. Please, let us know your thoughts.A New Era for Compliance TechnologyCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 29 - 2020, Vol 06 - Issue 34 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Jaxon JaseTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >